Here’s what you should know:
1. Boston Scientific notified employees about the layoffs in October 2017 and informed them the plant’s operations would move to another location, a company representative told the Boston Business Journal.
2. The neuromodulation plant will continue to house research and development, customer service and sales operations.
3. This is the company’s second round of layoffs this year. In February, Boston Scientific laid off 289 employees from another site that made neuromodulation products.
4. The company said in a statement to the Boston Business Journal, “We appreciate the contributions and commitment of the employees directly impacted by this decision. The Burlington team can take pride in the legacy of their accomplishments and dedication to innovation and quality. We understand that this will be a difficult time for those impacted and their families, and we are providing support to help them through the transition.”
More articles on supply chain:
Gastro Health acquires largest private practice in Orlando — 4 insights
Nobilis Health reports disappointing Q2 earnings & more — 6 ASC company key notes
CMS selects Florida-based spine ASC as first adopter for BPCI Advanced spine bundles: 3 key questions with Dr. Robert Masson
